INBP
Integrated Biopharma Inc
$0.16
-0.01 (-5.88%)
At close · Jul 8
Market Cap
$4.97M
Shares
31,059,610
Earnings calls and other investor events (conferences, investor days) grouped as single events — the transcript and audio, plus, for earnings calls, the 8-K earnings release and the quarter's 10-Q or 10-K, with the reported result and management tone at a glance.
Revenue & result across quarters
Revenue ($B) YoY up YoY down artefacts
LATEST
▼27.5%
'26 Q3
26-05-08
▼10.6%
'26 Q2
26-02-11
▼6.8%
'26 Q1
25-11-10
▲11.2%
'25 Q4
25-09-23
▲6.1%
'25 Q3
25-05-14
▲9.6%
'25 Q2
25-02-13
▲5.4%
'25 Q1
24-11-14
▼1.9%
'24 Q4
24-09-23
▲0.4%
'24 Q3
24-05-10
▼6.1%
'24 Q2
24-02-12
▲4.8%
'24 Q1
23-11-09
·
'23 Q4
23-09-15
▼16.2%
'23 Q3
23-05-11
▼16%
'23 Q2
23-02-10
·
'23 Q1
22-11-14
Earnings call
FY26 · Q3
2026-05-08
Integrated Biopharma Inc Q3 FY2026 Earnings Call
Revenue
$10.11M
▼ 27.5% YoY Diluted EPS
$-0.03
▼ 250% YoY Gross margin
-2.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q2
2026-02-11
Integrated Biopharma Inc Q2 FY2026 Earnings Call
Revenue
$11.28M
▼ 10.6% YoY Diluted EPS
$-0.03
Gross margin
0.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q1
2025-11-10
Integrated Biopharma Inc Q1 FY2026 Earnings Call
Revenue
$12.69M
▼ 6.8% YoY Diluted EPS
$0.00
▼ 100% YoY Gross margin
8.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2025-09-23
Integrated Biopharma Inc Q4 FY2025 Earnings Call
Revenue
$14.18M*
▲ 11.2% YoY Gross margin
10.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-05-14
Integrated Biopharma Inc Q3 FY2025 Earnings Call
Revenue
$13.95M
▲ 6.1% YoY Diluted EPS
$0.02
▲ 100% YoY Gross margin
11.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-02-13
Integrated Biopharma Inc Q2 FY2025 Earnings Call
Revenue
$12.61M
▲ 9.6% YoY Diluted EPS
$0.00
Gross margin
9.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2024-11-14
Integrated Biopharma Inc Q1 FY2025 Earnings Call
Revenue
$13.62M
▲ 5.4% YoY Diluted EPS
$0.01
Gross margin
10.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2024-09-23
Integrated Biopharma Inc Q4 FY2024 Earnings Call
Revenue
$12.75M*
▼ 1.9% YoY Gross margin
10.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-05-10
Integrated Biopharma Inc Q3 FY2024 Earnings Call
Revenue
$13.15M
▲ 0.4% YoY Diluted EPS
$0.01
Gross margin
9.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-02-12
Integrated Biopharma Inc Q2 FY2024 Earnings Call
Revenue
$11.51M
▼ 6.1% YoY Gross margin
4.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2023-11-09
Integrated Biopharma Inc Q1 FY2024 Earnings Call
Revenue
$12.91M
▲ 4.8% YoY Gross margin
6.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2023-09-15
Integrated Biopharma Inc Q4 FY2023 Earnings Call
Revenue
$12.99M*
Gross margin
7.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-05-11
Integrated Biopharma Inc Q3 FY2023 Earnings Call
Revenue
$13.10M
▼ 16.2% YoY Diluted EPS
$0.00
▼ 100% YoY Gross margin
7.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-02-10
Integrated Biopharma Inc Q2 FY2023 Earnings Call
Revenue
$12.25M
▼ 16% YoY Diluted EPS
$0.03
▲ 0% YoY Gross margin
8.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2022-11-14
Integrated Biopharma Inc Q1 FY2023 Earnings Call
Revenue
$12.33M
Diluted EPS
$0.00
Gross margin
8.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2022-09-14
Integrated Biopharma Inc Q4 FY2022 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-05-12
Integrated Biopharma Inc Q3 FY2022 Earnings Call
Revenue
$15.63M
▼ 8.4% YoY Diluted EPS
$0.03
▼ 25% YoY Gross margin
12.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-02-10
Integrated Biopharma Inc Q2 FY2022 Earnings Call
Revenue
$14.59M
▲ 2.4% YoY Diluted EPS
$0.03
▼ 25% YoY Gross margin
12.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2021-11-10
Integrated Biopharma Inc Q1 FY2022 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2021-09-02
Integrated Biopharma Inc Q4 FY2021 Earnings Call
Revenue
$19.48M*
▲ 43.9% YoY Gross margin
16.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-05-13
Integrated Biopharma Inc Q3 FY2021 Earnings Call
Revenue
$17.07M
▲ 25.2% YoY Diluted EPS
$0.04
▲ 33.3% YoY Gross margin
15.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-02-12
Integrated Biopharma Inc Q2 FY2021 Earnings Call
Revenue
$14.26M
▲ 0.4% YoY Diluted EPS
$0.04
▲ 33.3% YoY Gross margin
15.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2020-11-12
Integrated Biopharma Inc Q1 FY2021 Earnings Call
Revenue
$12.75M
▲ 11.8% YoY Diluted EPS
$0.02
▲ 100% YoY Gross margin
11.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q3
2020-05-14
Integrated Biopharma Inc Q3 FY2020 Earnings Call
Revenue
$13.63M
▼ 3.2% YoY Diluted EPS
$0.03
▲ 0% YoY Gross margin
13.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-02-12
Integrated Biopharma Inc Q2 FY2020 Earnings Call
Revenue
$14.20M
▲ 18.3% YoY Diluted EPS
$0.03
▲ 200% YoY Gross margin
14.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Showing 1–25 of 25 earnings calls